Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7616012

Concept 2021-04-01 to
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-12-31
2020-10-01 to
2020-12-31
2020-04-01 to
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
448,082,000 JPY
602,749,000 JPY
414,578,000 JPY
Ordinary profit (loss)
-232,900,000 JPY
-310,511,000 JPY
-299,846,000 JPY
Net assets
1,383,600,000 JPY
1,629,282,000 JPY
1,644,658,000 JPY
Total assets
1,715,442,000 JPY
1,838,038,000 JPY
1,996,568,000 JPY
Basic earnings (loss) per share
-26.14
-4.74
-34.23
-7.85
-32.61
Diluted earnings per share
Equity-to-asset ratio
0.807 xbrli:pure
0.885 xbrli:pure
0.824 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.